Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IND+LRPEP: Prevention of Post-ERCP Pancreatitis
NCT02641561Phase 3Completed
- Sponsor
- Cooper University Health Care
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin, lactated ringer's solution in acute pancreatitis (AP), sponsored by Cooper University Health Care. Started Oct 2014; status: completed.
02
Drugs
indomethacinlactated ringer's solution
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02641561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641561.